1. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presen- tation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000; 102(17):2031–7. https://doi.org/10.1161/01.cir.102.17.2031 PMID: 11044416
2. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: pro- spective multinational observational study (GRACE). Bmj. 2006; 333(7578):1091. https://doi.org/10. 1136/bmj.38985.646481.55 PMID: 17032691
3. Ishihara M, Kojima S, Sakamoto T, Asada Y, Kimura K, Miyazaki S, et al. Usefulness of combined white blood cell count and plasma glucose for predicting in-hospital outcomes after acute myocardial infarc- tion. Am J Cardiol. 2006; 97(11):1558–63. https://doi.org/10.1016/j.amjcard.2005.12.044 PMID: 16728213
4. Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, et al. Prediction of mortality after pri- mary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol. 2005; 45(9):1397–405. https://doi.org/10.1016/j.jacc.2005.01.041 PMID: 15862409
5. McNamara RL, Kennedy KF, Cohen DJ, Diercks DB, Moscucci M, Ramee S, et al. Predicting In-Hospi- tal Mortality in Patients With Acute Myocardial Infarction. J Am Coll Cardiol. 2016; 68(6):626–35. https:// doi.org/10.1016/j.jacc.2016.05.049 PMID: 27491907
6. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-seg- ment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2):119–77. https:// doi.org/10.1093/eurheartj/ehx393 PMID: 28886621
7. Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, et al. JCS 2018 Guideline on Diag- nosis and Treatment of Acute Coronary Syndrome. Circ J. 2019; 83(5):1085–196. https://doi.org/10. 1253/circj.CJ-19-0133 PMID: 30930428
8. Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, et al. JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure—Digest Version. Circ J. 2019; 83(10):2084–184. https://doi.org/10.1253/circj.CJ-19-0342 PMID: 31511439
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glo- merular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of internal medicine. 1999; 130(6):461–70. https://doi.org/10.7326/0003- 4819-130-6-199903160-00002 PMID: 10075613
10. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53(6):982–92. https://doi.org/10.1053/j.ajkd. 2008.12.034 PMID: 19339088
11. Veltman CE, de Graaf FR, Schuijf JD, van Werkhoven JM, Jukema JW, Kaufmann PA, et al. Prognostic value of coronary vessel dominance in relation to significant coronary artery disease determined with non-invasive computed tomography coronary angiography. Eur Heart J. 2012; 33(11):1367–77. https:// doi.org/10.1093/eurheartj/ehs034 PMID: 22390913
12. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985; 5(3):587–92. https://doi.org/10.1016/s0735-1097(85)80380-6 PMID: 3156171
13. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985; 312 (14):932–6. https://doi.org/10.1056/NEJM198504043121437 PMID: 4038784
14. Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, et al. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Circulation. 2018; 137(9):961–72. https://doi.org/10. 1161/CIRCULATIONAHA.117.033502 PMID: 29483172
15. Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D, et al. Prognostic significance of atrial fibrilla- tion/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary inter- vention. Am J Cardiol. 2003; 92(10):1150–4. https://doi.org/10.1016/j.amjcard.2003.07.021 PMID: 14609587
16. Kasanuki H, Honda T, Haze K, Sumiyoshi T, Horie T, Yagi M, et al. A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: rationale and initial results of the HIJAMI Registry. Am Heart J. 2005; 150(3):411–8. https://doi.org/10.1016/j.ahj. 2004.10.001 PMID: 16169317
17. Ishihara M, Fujino M, Ogawa H, Yasuda S, Noguchi T, Nakao K, et al. Clinical Presentation, Manage- ment and Outcome of Japanese Patients With Acute Myocardial Infarction in the Troponin Era—Japa- nese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET). Circ J. 2015; 79(6):1255–62. https://doi.org/10.1253/circj.CJ-15-0217 PMID: 25912696
18. Miyachi H, Takagi A, Miyauchi K, Yamasaki M, Tanaka H, Yoshikawa M, et al. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort. Heart Vessels. 2016; 31(11):1740–51. https://doi. org/10.1007/s00380-015-0791-9 PMID: 26758733
19. Ozaki Y, Katagiri Y, Onuma Y, Amano T, Muramatsu T, Kozuma K, et al. CVIT expert consensus docu- ment on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018. Cardiovascular intervention and therapeutics. 2018; 33(2):178–203. https://doi.org/10.1007/s12928-018-0516-y PMID: 29594964
20. Kristensen SD, Laut KG, Fajadet J, Kaifoszova Z, Kala P, Di Mario C, et al. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. Eur Heart J. 2014; 35(29):1957–70. https://doi.org/10.1093/eurheartj/eht529 PMID: 24419804
21. Pedersen F, Butrymovich V, Kelbæk H, Wachtell K, Helqvist S, Kastrup J, et al. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol. 2014; 64(20):2101–8. https://doi.org/10.1016/j.jacc.2014.08.037 PMID: 25457398
22. Granger CB, Bates ER, Jollis JG, Antman EM, Nichol G, O’Connor RE, et al. Improving Care of STEMI in the United States 2008 to 2012. Journal of the American Heart Association. 2019; 8(1). https://doi. org/10.1161/JAHA.118.008096 PMID: 30596310
23. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361(9351):13–20. https://doi.org/10.1016/S0140-6736(03)12113-7 PMID: 12517460
24. Cui Y, Hao K, Takahashi J, Miyata S, Shindo T, Nishimiya K, et al. Age-Specific Trends in the Incidence and In-Hospital Mortality of Acute Myocardial Infarction Over 30 Years in Japan—Report From the Miyagi AMI Registry Study. Circ J. 2017; 81(4):520–8. https://doi.org/10.1253/circj.CJ-16-0799 PMID: 28154296
25. Webb JG, Sleeper LA, Buller CE, Boland J, Palazzo A, Buller E, et al. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000; 36 (3 Suppl A):1084–90. https://doi.org/10.1016/s0735-1097(00)00876-7 PMID: 10985709
26. Menon V, Webb JG, Hillis LD, Sleeper LA, Abboud R, Dzavik V, et al. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Regis- try. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. 2000; 36(3 Suppl A):1110–6. https://doi.org/10.1016/s0735-1097(00)00878-0 PMID: 10985713
27. Slater J, Brown RJ, Antonelli TA, Menon V, Boland J, Col J, et al. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Regis- try. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol. 2000; 36(3 Suppl A):1117–22. https://doi.org/10.1016/s0735-1097(00)00845-7 PMID: 10985714
28. French JK, Hellkamp AS, Armstrong PW, Cohen E, Kleiman NS, O’Connor CM, et al. Mechanical com- plications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX- AMI). Am J Cardiol. 2010; 105(1):59–63. https://doi.org/10.1016/j.amjcard.2009.08.653 PMID: 20102891
29. French JK, Williams BF, Hart HH, Wyatt S, Poole JE, Ingram C, et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. Bmj. 1996; 312(7047):1637–41. https://doi.org/ 10.1136/bmj.312.7047.1637 PMID: 8664716
30. Figueras J, Alcalde O, Barrabe´s JA, Serra V, Alguersuari J, Cortadellas J, et al. Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period. Circulation. 2008; 118(25):2783–9. https://doi.org/10.1161/CIRCULATIONAHA.108. 776690 PMID: 19064683
31. Figueras J, Cortadellas J, Calvo F, Soler-Soler J. Relevance of delayed hospital admission on develop- ment of cardiac rupture during acute myocardial infarction: study in 225 patients with free wall, septal or papillary muscle rupture. J Am Coll Cardiol. 1998; 32(1):135–9. https://doi.org/10.1016/s0735-1097(98) 00180-6 PMID: 9669261
32. Hara M, Sakata Y, Nakatani D, Suna S, Nishino M, Sato H, et al. Impact of coronary collaterals on in- hospital and 5-year mortality after ST-elevation myocardial infarction in the contemporary percutaneous coronary intervention era: a prospective observational study. BMJ open. 2016; 6(7):e011105. https:// doi.org/10.1136/bmjopen-2016-011105 PMID: 27412101
33. Allahwala UK, Weaver JC, Nelson GI, Nour D, Ray M, Ciofani JL, et al. Effect of Recruitment of Acute Coronary Collaterals on In-Hospital Mortality and on Left Ventricular Function in Patients Presenting With ST Elevation Myocardial Infarction. Am J Cardiol. 2020; 125(10):1455–60. https://doi.org/10.1016/ j.amjcard.2020.02.023 PMID: 32245631
34. Kim EK, Choi JH, Song YB, Hahn JY, Chang SA, Park SJ, et al. A protective role of early collateral blood flow in patients with ST-segment elevation myocardial infarction. Am Heart J. 2016; 171(1):56–63. https://doi.org/10.1016/j.ahj.2015.10.016 PMID: 26699601
35. Ndrepepa G, Mehilli J, Schulz S, Iijima R, Keta D, Byrne RA, et al. Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syn- dromes. J Am Coll Cardiol. 2008; 52(7):512–7. https://doi.org/10.1016/j.jacc.2008.05.009 PMID: 18687242
36. Kenner MD, Zajac EJ, Kondos GT, Dave R, Winkelmann JW, Joftus J, et al. Ability of the no-reflow phe- nomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month fol- low-up. Am J Cardiol. 1995; 76(12):861–8. https://doi.org/10.1016/s0002-9149(99)80250-1 PMID: 7484821
37. Ali M, Lange SA, Wittlinger T, Lehnert G, Rigopoulos AG, Noutsias M. In-hospital mortality after acute STEMI in patients undergoing primary PCI. Herz. 2018; 43(8):741–5. https://doi.org/10.1007/s00059- 017-4621-y PMID: 28993843
38. Kim SS, Choi HS, Jeong MH, Cho JG, Ahn YK, Kim JH, et al. Clinical outcomes of acute myocardial infarction with occluded left circumflex artery. J Cardiol. 2011; 57(3):290–6. https://doi.org/10.1016/j. jjcc.2011.01.014 PMID: 21388789
39. Huey BL, Beller GA, Kaiser DL, Gibson RS. A comprehensive analysis of myocardial infarction due to left circumflex artery occlusion: comparison with infarction due to right coronary artery and left anterior descending artery occlusion. J Am Coll Cardiol. 1988; 12(5):1156–66. https://doi.org/10.1016/0735- 1097(88)92594-6 PMID: 3170958
40. Ilia R, Cafri C, Weinstein JM, Gueron M. Acute myocardial infarction due to occlusion of the dominant left circumflex artery proximally. Am J Cardiol. 2003; 92(1):54–5. https://doi.org/10.1016/s0002-9149 (03)00465-x PMID: 12842246
41. Hirji SA, Stevens SR, Shaw LK, Campbell EC, Granger CB, Patel MR, et al. Predicting risk of cardiac events among ST-segment elevation myocardial infarction patients with conservatively managed non- infarct-related artery coronary artery disease: An analysis of the Duke Databank for Cardiovascular Dis- ease. Am Heart J. 2017; 194:116–24. https://doi.org/10.1016/j.ahj.2017.08.023 PMID: 29223429
42. Fresco C, Avanzini F, Bosi S, Franzosi MG, Maggioni AP, Santoro L, et al. Prognostic value of a history of hypertension in 11,483 patients with acute myocardial infarction treated with thrombolysis. GISSI-2 Investigators. Gruppo Italiano per lo Studio della, Sopravvivena nell’Infarto Miocardico. J Hypertens. 1996; 14(6):743–50. https://doi.org/10.1097/00004872-199606000-00010 PMID: 8793697
43. Suzuki N, Asano T, Nakazawa G, Aoki J, Tanabe K, Hibi K, et al. Clinical expert consensus document on quantitative coronary angiography from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovascular intervention and therapeutics. 2020; 35(2):105–16. https://doi.org/ 10.1007/s12928-020-00653-7 PMID: 32125622